Marion Le Meur

Marion Le Meur studied pharmacy at the University of Rennes (France) and she simultaneously obtained a MSc in Pharmaceutics at the Paris Cité University (France). Her master’s thesis was conducted at the University of Montreal (Canada) and focused on the development of solid lipid nanoparticles for the oral delivery of a drug candidate for phase II clinical trials. Currently, she is pursuing a PhD at IMDEA Nanociencia, working on the development of multi-functionalized nano-drug delivery systems to target circadian clock dysfunctions in Alzheimer’s disease, as part of the European project TClock4AD.